COMMUNIQUÉS West-GlobeNewswire

-
Cedar Gate Data Finds Nearly 60% of New Mothers Miss Essential Postpartum Follow-Up Care
29/07/2025 -
IMUNON to Hold Second Quarter 2025 Financial Results and Business Update Conference Call on Tuesday, August 5, 2025
29/07/2025 -
Foundation Health to Bring AI-Powered Patient Communication to Intermountain Health’s Specialty Pharmacy Patients
29/07/2025 -
Quoin Pharmaceuticals Provides Product Portfolio Update
29/07/2025 -
Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference
29/07/2025 -
CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference
29/07/2025 -
The International Myeloma Foundation Mourns the Loss of Accomplished Attorney and Longtime Board Member Benson Klein
29/07/2025 -
Cannabix Technologies Receives Notice of Allowance from CIPO for Contactless Breath Analysis Patent Application
29/07/2025 -
New Imprivata Report: Hospitals Save an Average of $1.1M Annually with Shared Mobile Devices, But Most Still Lack a Formal Use Policy
29/07/2025 -
Concept Life Sciences & Fios Genomics Partner to Enhance Complex Data Analysis in Drug Discovery
29/07/2025 -
Meliodays and Celanese Partner for Meliodays’ Development of Hormone-Free Non-Contraceptive IUD designed to Treat Menstrual Pain
29/07/2025 -
Philips builds strong order intake momentum and drives margin expansion in Q2
29/07/2025 -
Indonesia’s Ministry of Health and Philips to deliver nationwide coverage of advanced image-guided therapy systems in Indonesia, expanding access to cardiac, stroke and cancer care in all 38 provinces
29/07/2025 -
Basilea initiates phase 3 study with antifungal fosmanogepix in invasive mold infections
29/07/2025 -
LIfT BioSciences announces grant of €12 million from Ireland’s Disruptive Technologies Innovation Fund to support the first-in-human clinical trial of LIfT’s IMAN therapy
29/07/2025 -
Regional Health Properties, Inc. Outlines Reasons for Regional Shareholders to Vote YES for Proposed Merger with SunLink Health Systems, Inc.
29/07/2025 -
Strength Building: How Strength Training Supplements Help You Build Muscle Mass and Keep Growing Stronger - CrazyBulk
29/07/2025 -
FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
29/07/2025 -
Unity Consortium Announces Publication of Journal of Adolescent Health Supplement: “Expert Perspectives on Evolving Adolescent Well Visits and Immunization Platforms”
28/07/2025
Pages